| abstract |
FIELD: medicine; biotechnology. n SUBSTANCE: invention relates to biotechnology, specifically to amylin receptor agonists, and can be used in medicine. Invention is an analogue of pramlintide, selectively modified by substituents, fatty carboxylic acids, at different positions of the amino acid sequence. n EFFECT: such pramlintide analogues can act as an effective antidiabetic agent and serve to treat patients with metabolic disorders and the ability to utilise glucose. n 14 cl, 4 dwg, 15 tbl, 10 ex |